Guideline on the management of bleeding in patients on antithrombotic agents

被引：151

作者：

Makris, Mike ^{[1
,2
]}

Van Veen, Joost J. ^{[2
]}

Tait, Campbell R. ^{[3
]}

Mumford, Andrew D. ^{[4
]}

Laffan, Mike ^{[5
]}

机构：

[1] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England

[2] Sheffield Teaching Hosp NHS Trust, Sheffield Haemophilia & Thrombosis Ctr, Sheffield, S Yorkshire, England

[3] Glasgow Royal Infirm, Dept Haematol, Glasgow G4 0SF, Lanark, Scotland

[4] Univ Bristol, Bristol Royal Infirm, Bristol Heart Inst, Bristol, Avon, England

[5] Univ London Imperial Coll Sci Technol & Med, Acad Hlth Sci Ctr, Hammersmith Hosp, London, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2013年 / 160卷 / 01期

关键词：

anticoagulant; antithrombotic; antiplatelet; reversal; bleeding; RECOMBINANT FACTOR VIIA; HEPARIN-INDUCED THROMBOCYTOPENIA; PROTHROMBIN COMPLEX CONCENTRATE; ACUTE MYOCARDIAL-INFARCTION; MOLECULAR-WEIGHT HEPARIN; ACTIVATED FACTOR-VII; CARDIOPULMONARY BYPASS; THROMBOLYTIC THERAPY; THROMBIN GENERATION; PLATELET-FUNCTION;

D O I：

10.1111/bjh.12107

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：35 / 46

页数：12

共 102 条

[1] Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation [J].

Ainle, Fionnuala Ni ;

Preston, Roger J. S. ;

Jenkins, P. Vincent ;

Nel, Hendrik J. ;

Johnson, Jennifer A. ;

Smith, Owen P. ;

White, Barry ;

Fallon, Padraic G. ;

O'Donnell, James S. .

BLOOD, 2009, 114 (08) :1658-1665

[2] Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation [J].

Altman, R. ;

Scazziota, A. ;

De Lourdes Herrera, M. ;

Gonzalez, C. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (09) :2022-2027

[3] The effects of heparinase 1 and protamine on platelet reactivity [J].

Ammar, T ;

Fisher, CF .

ANESTHESIOLOGY, 1997, 86 (06) :1382-1386

[4]

[Anonymous], HAEMATOL HEMATOL S1

[5]

BANG CJ, 1991, HAEMOSTASIS, V21, P155

[6] NEW VARIANT OF HUMAN TISSUE-PLASMINOGEN ACTIVATOR (TPA) WITH ENHANCED EFFICACY AND LOWER INCIDENCE OF BLEEDING COMPARED WITH RECOMBINANT HUMAN TPA [J].

BENEDICT, CR ;

REFINO, CJ ;

KEYT, BA ;

PAKALA, R ;

PAONI, NF ;

THOMAS, GR ;

BENNETT, WF .

CIRCULATION, 1995, 92 (10) :3032-3040

[7]

Berkowitz SD, 1997, CIRCULATION, V95, P809

[8] Anticipating and managing bleeding complications in patients with coronary stents who are receiving dual antiplatelet treatment [J].

Bhala, Neeraj ;

Taggar, Jaspal S. ;

Rajasekhar, Praveen ;

Banerjee, Amitava .

BMJ-BRITISH MEDICAL JOURNAL, 2011, 343

[9] Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers [J].

Bijsterveld, NR ;

Moons, AH ;

Boekholdt, SM ;

van Aken, BE ;

Fennema, H ;

Peters, RJG ;

Meijers, JCM ;

Büller, HR ;

Levi, M .

CIRCULATION, 2002, 106 (20) :2550-2554

[10] Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate* [J].

Blomback, Margareta ;

He, Shu ;

Bark, Niklas ;

Wallen, Hakan N. ;

Elg, Margareta .

BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (06) :758-765

← 1 2 3 4 5 6 7 8 9 10 →